Inhibrx Biosciences, Inc. (INBX)

Healthcare · Biotechnology · NASDAQ

Inhibrx Biosciences, Inc. (INBX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.30B and a free-cash-flow yield of -9.5%. Over the most recent reported fiscal year, revenue grew 550.0%.

Market cap	$1.30B
Trailing P/E	—
FCF yield	-9.5%
Revenue growth (YoY)	+550.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live INBX data on Nama Insights →